Oct 27, 2021News ArticlesAn Interchangeable Biosimilars vs Authorized Biologics Battle May Be LoomingCompetitors in the field of adalimumab and insulin products may soon include authorized biologics.
Oct 22, 2021News ArticlesAMCP Nexus 2021: A Wrap-UpBiosimilar adoption and biosimilar market share were among the featured topics at the AMCP Nexus 2021 meeting in Denver, Colorado.
Oct 21, 2021News ArticlesAMCP Nexus 2021: Biosimilars Are Gathering Momentum — and Interchangeability May Not MatterIPD Analytics discussed biosimilar uptake as both biosimilar market share and adoption of biosimilars become more prominent.
Apr 21, 2021News ArticlesFurther Dissecting the Launch of Adalimumab Biosimilars in the USAccording to the IPD Analytics team, an adalimumab biosimilar launch may occur as early as late 2022.